About GenSci
Our Values
Production Sites
Counterfeiting
Contact Us
R&D
Technology
Press Releases
中
金赛子公司
Time
2022-08-07
Readership
656
Share
金赛药业重组人生长激素注射液特发性矮小适应症获批。